Choice India Broker Research reports

The Reserve Bank of India (RBI), in its fifth bi-monthly monetary policy statement' 201718, kept the policy rate unchanged at 6.0% and maintained neutral policy stance, in line with the our expectation. Interest rate easing cycle which started in Jan'2015 is now viewing to close due to increase in the upside risks to inflation. Amidst increasing uncertainties to inflation path, which the RBI keeps top of its agenda for policy rate...

SHL is engaged in the business of providing tertiary and quaternary Face Value healthcare services with a focus on orthopaedics. SHL provides inpatient and outpatient healthcare services through 11 operational Shares for fresh issue...

Axis Bank Ltd. (AxisB) Q2FY18 numbers came below our estimation with net profit plummeting 67% QoQ to Rs4,323.8 mn due to high provisioning and weak NII growth. The bank reported higher slippage of Rs89.4 bn and profitability declined due to high credit cost, however it reported strong growth in credit portfolio driven by healthy traction in retail advances. AxisB has approved its capital raising plan amounting to Rs116.3 bn which will help it to absorb credit costs and also...

IntraSoft Technologies Ltd. (ITL) a multi-channel e-commerce retailer, reported its Q2 FY18 numbers, which was above our expectations. The company reported a bottom-line of Rs. 39.5mn (declined by 26.8% Y-o-Y) on a top-line of...

CPI inflation increases to 3.6% in October CPI inflation or retail inflation rose to 7-month high at 3.6% in October as compared to 3.3% in previous month mainly driven by high vegetables and fuel prices. Inflation came higher than market expectation of 3.4% as vegetables' prices unexpectedly rose by 7.5% in October (3.9% in Sep'17) driven by rise in the prices of onions and tomatoes due to weather related disruption in supplies. Kharif onion crop, which accounts for around 40% of India's onion production, was impacted by the unseasonal rains, while tomatoes prices increased...

Q2FY18 Result Analysis: IndusB continued to witness strong growth in NII which grew by 24.7% YoY and 2.6% QoQ driven by strong credit growth and decline in cost Holding Period 12-18 Months of funds. In low interest rate scenario, while yield on advances declined by 19 bps to Upside Potential 25.7%...

Exchange traded fund (ETF) is one of the methods, by which the Government of India is disinvesting its stake in the central public sector enterprises (CPSE). The government would continue to use ETF as a vehicle for further disinvestment of shares. Accordingly, a new ETF (BHARAT 22 ETF) with diversified CPSE stocks and other government holdings was launched in Aug....

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations. Its business includes branded generics in emerging markets of Asia and Africa, generics in the developed markets of the United States and Institutional sales. The branded generics business is spread in India and over 30 emerging countries across Africa, Commonwealth of Independent States (CIS), the Middle East and South East Asia. Company's Institutional business comprises of supplies to various government bodies in India and supply of Anti-Malarial products under WHO approved programs in Africa....